Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis

Neuropathology and Applied Neurobiology

Volumn 28, Issue 6, 2002, Pages 480-488

  Cosenza, Melissa A ^a   Zhao, Meng Liang ^a   Shankar, Sai L ^a   Shafit Zagardo, Bridget ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; Microtubule associated protein; Myelin; Oligodendrocytes; White matter

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; CD68 ANTIGEN; FAST BLUE; GAG PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; VIRUS PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BRAIN SLICE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NERVE FIBER DEGENERATION; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; WHITE MATTER;

ADULT; AIDS DEMENTIA COMPLEX; BRAIN; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; OLIGODENDROGLIA; UP-REGULATION;

EID: 0036444245     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2002.00420.x     Document Type: Article

References (36)

1. Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, Gonzalez-Scarano F. HIV-1 infection of cultured human adult oligodendrocytes. Virology 1996; 217: 211-9
2. An SF, Giometto B, Groves M, Miller RF, Beckett AAJ, Gray F, Tavolato B, Scaravilli F. Axonal damage revealed by accumulation of b-APP in HIV-positive individuals with AIDS. J Neuropathol Exp Neurol 1997; 56: 1262-8
3. An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol (Berl) 1999; 98: 481-7
4. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10: 573-85
5. Bernardo A, Agresti C, Levi G. HIV-gp120 affects the functional activity of oligodendrocytes and their susceptibility to complement. J Neurosci Res 1997; 50: 946-57
6. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premy-elinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346: 165-73
7. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV. Neuropathology of the acquired immune deficiency syndrome (AIDS), report of 39 autopsies from Vancouver, British Columbia. Can J Neurol Sci 1992; 19: 442-52
8. Esiri MM, Morris CS, Millard PR. Fate of oligodendrocytes in HIV-1 infection. AIDS 1991; 5: 1081-8
9. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9
10. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities. Ann Neurol 1997; 42: 34-40
11. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantification of human immunodeficiency virus in the brain: Correlations with dementia. Ann Neurol 1995; 38: 755-62
12. Gray F, Lescs MC. HIV-related demyelinating disease. Eur J Med 1993; 2: 89-96
13. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991; 253: 320-3
14. Kolson DL, Lavi E, Gonzalez-Scarano F. The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 1998; 50: 1-47
15. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. New Engl J Med 1995; 332: 934-40
16. Liu J, Zhao M-L, Brosnan CF, Lee SC. Expression of type II nitric oxide synthase in primary human astrocytes and microglia. Role of IL-1b and IL-1 receptor antagonist. J Immunol 1996; 157: 3569-76
17. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61: 85-90
18. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-41
19. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IRS. Induction of interleukin-1 and tumor necrosis factor α in brain cultures by human immunodeficiency virus type 1. J Virol 1992; 66: 2217-25
20. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 17: 271-84
21. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986; 19: 517-24
22. Petito CK, Cash KS. Blood-brain barrier abnormalities in AIDS. Immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992; 32: 658-66
23. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann Neurol 1993; 34: 339-50
24. Raine CS, Moore GR, Hintzen R, Traugott U. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis. Laboratory Invest 1988; 59: 467-76
25. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM. Cerebral white matter damage in HIV infection demonstrated using β-amyloid precursor protein immunoreactivity. Acta Neuropathol 1997; 93: 184-9
26. Richter-Landsberg C. The oligodendroglia cytoskeleton in health and disease. J Neurosci Res 2000; 59: 11-8
27. Schmidbauer M, Huemer M, Cristina S, Trabattoni GR, Budka H. Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 1992; 18: 489-501
28. Selmaj K, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339-46
29. Shafit-Zagardo B, Kress Y, Zhao ML, Lee SC. A novel microtubule-associated protein reexpressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 1999; 73: 2531-7
30. Shafit-Zagardo B, Rockwood J, Davies P, Kress Y, Lee SC. MAP-2+13, a novel microtubule-associated protein expressed early in human oligodendrocyte maturation. Glia 2000; 29: 233-45
31. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta Neuropathol (Berl) 1994; 88: 433-9
32. Trapp BD, Nishiyama A, Cheng D, Macklin W. Differentiaion and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 1997; 137: 459-68
33. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998; 338: 278-85
34. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994; 36: 673-6
35. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R. Neocortical damage during HIV infection. Ann Neurol 1991; 29: 651-7
36. Zhao ML, Kim MO, Morgello S, Lee SC. Expression of iNOS, IL-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol 2001; 115: 182-91